Facebook
Twitter
LinkedIn
ForwardSubstance Use Disorders Management Boot Camp (October 12-13, 2023)
This training aims to enhance confidence and competencies related to the management of substance use disorders in general medical settings. Through case-based and interactive didactic content, the workshop will explore issues related to assessment, monitoring, prevention, and management of issues that commonly occur with substance use (for example addiction, infectious disease, mental health issues.
Intended Audience
This program is designed for physicians, advanced practice nurses, and nurses who treat patients with opioid use disorder.
Learning Objectives
As a result of participating in this activity, learners, as members of the healthcare team, will be able to:
- Determine accurate diagnosis and initiate treatment for opioid use disorder, alcohol withdrawal, and alcohol use disorder
- Demonstrate skills needed to work with patients who continue to use drugs and alcohol while in treatment for use disorder
- Determine appropriate treatment plan for OUD and AUD, including the initiation and maintenance of buprenorphine therapy, alcohol withdrawal management, and MAUD.
- Develop approaches to working with and managing patients with stimulant use disorders.
- Determine appropriate approach to evaluation and management of Hepatitis C.
Elements of Competence
This educational activity is designed to change learner competence and focuses on the following competencies:
- Accreditation Council for Graduate Medical Education (ACGME)/Nursing: Patient Care & Procedural Skills, Medical Knowledge, Interpersonal & Communication Skills, and Professionalism
- National Academy of Medicine (NAM)/Nursing: Provide patient/person-centered care, Employ evidence-based practice, and Population Health
- Interprofessional Education Collaborative Competencies: Values/ethics for interprofessional practice, Roles & Responsibilities, and Teams & Teamwork
- UW ICEP Diversity, Equity, and Inclusion: Engage in Self-reflection, Address Health Disparities, and Value Diversity in the Clinical Encounter.
All times listed are in Central Daylight Time (CDT)
| Thursday, October 12 | |
|---|---|
| 12:00 pm - 1:15 pm | Lunch & Conference Welcome |
| 1:15 pm - 3:15 pm | OUD Evaluation and Management & Inductionology: The Art of Buprenorphine Induction in the Age of Fentanyl Drs. Jillian Landeck & Allison Miller |
| 3:15 pm - 3:30 pm | Break |
| 3:30 pm - 4:00 pm | Stimulant Use Drs. David Leinweber & Randy Brown |
| 4:00 pm - 4:15 pm | Q&A |
| 4:15 pm - 5:00 pm | Small Group Case Discussionn |
| 5:00 pm | Adjourn Day 1 |
| 5:15 pm - 6:45 pm | Networking Reception |
| Friday, October 13 | |
| 8:30 am - 9:30 am | Harm Reduction Services for People Who Inject Drugs Jennifer Steele |
| 9:30 am - 10:00 am | PREP and Q&A Dr. Allison Miller |
| 10:00 am - 10:15 am | Break |
| 10:15 am - 11:30 am | Alcohol Use Disorder & Case Discussion Dr. Randy Brown |
| 11:30 am - 12:15 pm | Hep C Dr. Jillian Landeck |
| 12:15 pm - 1:00 pm | Lunch |
| 1:00 pm - 1:45 pm | Breakout Sessions (select one) |
| 1:45 pm - 2:00 pm | Break |
| 2:00 pm - 2:45 pm | Panel Discussion Drs. David Leinweber & Randy Brown |
| 2:45 pm - 3:00 pm | Wrap-Up, Q&A, and Resources |
| 3:00 pm | Adjourn |
The conference will take place in the Rasmus and Overholt Auditoriums, at Gundersen Health System in the Heritage building.
For additional questions, please contact Kathleen Maher, kathleen.maher@fammed.wisc.edu.
Learners are responsible for their own transportation and lodging.
Travel
Parking:
Gundersen Health System and affiliate staff: park in employee parking only(Lot C or F).
Non-Gundersen participants: park in the 
blue ramp. Please use the Overholt entrance.
.
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
Randy Brown, MD, PhD, DFASAM | Course Director | No relevant relationships with ineligible companies to disclose | Yes |
Kelly Eagen, MD | Planner | No relevant relationships with ineligible companies to disclose | No |
Jillian Landeck, MD | Planner | No relevant relationships with ineligible companies to disclose | No |
David Leinweber, MD | Planner | No relevant relationships with ineligible companies to disclose | Yes |
Jill Lindwall, RN | Planner | No relevant relationships with ineligible companies to disclose | No |
Alison Miller, MD | Planner | No relevant relationships with ineligible companies to disclose | No |
Amy Parins | Planner | No relevant relationships with ineligible companies to disclose | No |
Jennifer Steele | Planner | No relevant relationships with ineligible companies to disclose | Yes |
*Ineligible companies are those whose primary business is producing, marketing, selling, re‐selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
 | Accreditation Statement In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
American Medical Association (AMA) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. American Nurses Credentialing Center (ANCC) The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 8.25 ANCC contact hours, 5.25 of which are eligible for pharmacotherapeutic contact hours. Wisconsin Medical Examining Board Opioid CME This course is approved by the Wisconsin Medical Examining Board as meeting the requirements for a continuing education course on the responsible opioid prescribing guidelines per Med 13.03(3) of the Wisconsin Administrative Code. Course title: Substance Use Disorders Management Boot Camp (October 12-13, 2023) Medication Access and Training Expansion (MATE) Act This course is designed to meet the requirements outlined in the Medication Access and Training Expansion (MATE) Act. (Click here for more information.) | |
 | AAPA Category 1 CME credit – Live The University of Wisconsin–Madison ICEP has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. |
Continuing Education Units (CEUs) The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.825 CEUs or 8.25 hours. | |
Available Credit
- 8.25 AAPA Category 1 CME
- 7.50 Wisconsin Responsible Opioid Prescribing Credit
- 8.25 AMA PRA Category 1 Credit™
- 7.50 Wisconsin Responsible Opioid Prescribing Credit
- 8.25 ANCC Contact Hours
- 7.50 Wisconsin Responsible Opioid Prescribing Credit
- 5.25 ANCC Pharmacotherapy Contact Hours
- 8.25 University of Wisconsin–Madison Continuing Education Hours
- 8.25 Approved for AMA PRA Category 1 Credit™
- 7.50 Wisconsin Responsible Opioid Prescribing Credit
This activity is in-person only.
Registration for this activity can only be completed through the ICEP Learning Portal. Attendee registrations made through any other sites cannot be honored. UW-Madison ICEP is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com. Please report any unauthorized websites or solicitations for registrations to help@icep.wisc.edu.
QUESTIONS ABOUT EVENT & VENUE
Email Kathleen Maher kathleen.maher@fammed.wisc.edu
QUESTIONS REGARDING REGISTRATION
Email help@icep.wisc.edu.
PROGRAM CHANGES
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin School of Medicine and Public Health and the University of Wisconsin–Madison ICEP reserve the right to alter or substitute a topic or speaker without prior notification.
ACCESSIBILITY
The University of Wisconsin provides equal opportunities in employment and programming, including Title IX requirements. The University of Wisconsin fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us at help@icep.wisc.edu
FOR FURTHER INFORMATION
For additional questions about the conference, including accessibility requests, please contact: Kathleen Maher kathleen.maher@fammed.wisc.edu.